BioNexus Gene Lab Corp. (NASDAQ:BGLC) Sees Large Drop in Short Interest

BioNexus Gene Lab Corp. (NASDAQ:BGLC) was the recipient of a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 313,800 shares, a decrease of 61.7% from the January 15th total of 820,000 shares. Currently, 2.7% of the company’s stock are short sold. Based on an average daily trading volume, of 3,880,000 shares, the short-interest ratio is currently 0.1 days.

BioNexus Gene Lab Price Performance

BioNexus Gene Lab stock traded up $0.02 during mid-day trading on Thursday, reaching $0.38. 13,958 shares of the company’s stock were exchanged, compared to its average volume of 7,423,802. The company has a fifty day moving average of $0.33 and a 200-day moving average of $0.37. BioNexus Gene Lab has a twelve month low of $0.21 and a twelve month high of $1.40.

BioNexus Gene Lab Company Profile

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.